Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Shalini S Rao"'
Autor:
Maria Daglas, Phan H. Truong, Linh Q. Miles, Sydney M. A. Juan, Shalini S. Rao, Paul A. Adlard
Publikováno v:
British Journal of Pharmacology. 180:214-234
Traumatic brain injury (TBI) remains a leading cause of mortality and morbidity in young adults. The role of iron in potentiating neurodegeneration following TBI has gained recent interest as iron deposition has been detected in the injured brain in
Autor:
Shalini S. Rao, Paul Anthony Adlard
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 11 (2018)
There is an emerging link between the accumulation of iron in the brain and abnormal tau pathology in a number of neurodegenerative disorders, such as Alzheimer’s disease (AD). Studies have demonstrated that iron can regulate tau phosphorylation by
Externí odkaz:
https://doaj.org/article/5b6b3572aae24ca7b4a9ca04ad9c52db
Autor:
Shalini S. Rao, Larissa Lago, Irene Volitakis, Jay J. Shukla, Gawain McColl, David I. Finkelstein, Paul A. Adlard
Publikováno v:
Neurotherapeutics. 18:2759-2761
Autor:
David Finkelstein, Shalini S Rao, Paul A. Adlard, Irene Volitakis, Gawain McColl, Larissa Lago, Jay J. Shukla
Publikováno v:
Neurotherapeutics
The accumulation of neurofibrillary tangles (NFTs), which is composed of abnormally hyperphosphorylated tau aggregates, is the classic neuropathology associated with cognitive dysfunction in tauopathies such as Alzheimer’s disease (AD). However, th
Publikováno v:
Journal of Alzheimer's disease : JAD. 78(4)
Background Abnormally hyperphosphorylated tau is a defining pathological feature of tauopathies, such as Alzheimer's disease (AD), and accumulating evidence suggests a role for iron in mediating tau pathology that may lead to cognitive decline in the
Autor:
Shalini S, Rao, Stuart D, Portbury, Larissa, Lago, Gawain, McColl, David I, Finkelstein, Ashley I, Bush, Paul A, Adlard
Publikováno v:
Journal of Alzheimer's disease : JAD. 77(2)
Abnormally hyperphosphorylated tau is a defining pathological feature of tauopathies, such as Alzheimer's disease (AD), and accumulating evidence suggests a role for iron in mediating tau pathology that may lead to cognitive decline in these conditio
Autor:
Philip Doble, Paul A. Adlard, Raquel Gonzalez de Vega, Shalini S Rao, Dominic J. Hare, Larissa Lago, David Clases, Lisa Bray
Publikováno v:
Metallomics : integrated biometal science. 12(2)
A dysregulation in the homeostasis of metals such as copper, iron and zinc is speculated to be involved in the pathogenesis of tauopathies, which includes Alzheimer's disease (AD). In particular, there is a growing body of evidence to support a role
Autor:
Paul A. Adlard, Shalini S Rao
Publikováno v:
Frontiers in Molecular Neuroscience
Frontiers in Molecular Neuroscience, Vol 11 (2018)
Frontiers in Molecular Neuroscience, Vol 11 (2018)
There is an emerging link between the accumulation of iron in the brain and abnormal tau pathology in a number of neurodegenerative disorders, such as Alzheimer's disease (AD). Studies have demonstrated that iron can regulate tau phosphorylation by i
Autor:
Fossmark R; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway; Department of Gastroenterology and Hepatology, St. Olav's University Hospital, Trondheim, Norway. Electronic address: reidar.fossmark@ntnu.no., Rao S; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway. Electronic address: shalini.rao@ntnu.no., Mjønes P; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway; Department of Pathology, St. Olav's University Hospital, Trondheim, Norway. Electronic address: patricia.mjones@ntnu.no., Munkvold B; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway. Electronic address: bjorn.munkvold@ntnu.no., Flatberg A; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway. Electronic address: arnar.flatberg@ntnu.no., Varro A; Department of Cell and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. Electronic address: a.varro@liverpool.ac.uk., Thommesen L; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway. Electronic address: liv.thommesen@ntnu.no., Nørsett KG; Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway; The Central Norway Regional Health Authority, Trondheim, Norway. Electronic address: kristin.norsett@ntnu.no.
Publikováno v:
Peptides [Peptides] 2016 May; Vol. 79, pp. 83-94. Date of Electronic Publication: 2016 Mar 30.
Autor:
Zub KA; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Sousa MM; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Sarno A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Sharma A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway; PROMEC Core Facility for Proteomics and Metabolomics, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Demirovic A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Rao S; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Young C; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Aas PA; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Ericsson I; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Sundan A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway., Jensen ON; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark., Slupphaug G; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology NTNU, Trondheim, Norway; PROMEC Core Facility for Proteomics and Metabolomics, Norwegian University of Science and Technology NTNU, Trondheim, Norway.
Publikováno v:
PloS one [PLoS One] 2015 Mar 13; Vol. 10 (3), pp. e0119857. Date of Electronic Publication: 2015 Mar 13 (Print Publication: 2015).